O-glcnac-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Isono, Takahiro ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; CD98 ANTIGEN; CTD110.6; DOLICHOL PHOSPHATE; GLYCOPROTEIN; HEAT SHOCK PROTEIN 70; LAMININ BETA3; MANNOSE; N ACETYLGLUCOSAMINE; OXYGEN REGULATED PROTEIN 150; PROTEIN ANTIBODY; PROTEIN MAC2BP; TRANSFERASE; TUNICAMYCIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE; CHITOBIOSYLDIPHOSPHODOLICHOL BETA MANNOSYLTRANSFERASE; CHITOBIOSYLDIPHOSPHODOLICHOL BETA-MANNOSYLTRANSFERASE; GLUCOSE; MANNOSYLTRANSFERASE; MONOCLONAL ANTIBODY; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; CELL STRESS; CONTROLLED STUDY; CROSS REACTION; EMBRYO; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEOMICS; UPREGULATION; DRUG EFFECT; GLYCOSYLATION; IMMUNOLOGY; METABOLISM; REPRODUCIBILITY; TUMOR CELL LINE;

ACETYLGLUCOSAMINE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL LINE, TUMOR; CROSS REACTIONS; GLUCOSE; GLYCOSYLATION; HUMANS; MANNOSYLTRANSFERASES; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 79955451720     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018959     Document Type: Article

References (24)

1. Kageyama S, Isono T, Iwaki H, Wakabayashi Y, Okada Y, et al. (2004) Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chem 50: 857-866.
2. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, et al. (2004) Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma-synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci 95: 955-961.
3. Kageyama S, Iwaki H, Inoue H, Isono T, Yuasa T, et al. (2007) A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma. Proteomics Clin Appl 1: 192-199.
4. Isono T, Kim CJ, Ando Y, Sakurai H, Okada Y, et al. (2009) Supressin of cell invasiveness by periostin via TAB1/TAK1. Int J Oncol 35: 425-432.
5. Zachara NE, Hart GW, (2004) O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673: 13-28.
6. Hart GW, Housley MP, Slawson C, (2007) Cycling of O-inked β-N-acetylgulcosamine on nucleocytoplasmic proteins. Nature 446: 1017-1022.
7. Butkinaree C, Park K, Hart GW, (2010) O-inked β-N-acetylgulcosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 2010: 96-106.
8. Bouche C, Serdy S, Kahn CR, Goldfine AB, (2004) The cellular fate of gulucose and its relevance in type 2 diabetes. Endcrine Rev 25: 807-830.
9. Taylor RP, Parker GJ, Hazel MW, Soesanto Y, Fuller W, et al. (2008) Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-inked N-acetylgulcosaminyltransferase. J Biol Chem 283: 6050-6057.
10. Cheung WD, Hart GW, (2008) AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal protein during glucose deprivation. J Biol Chem 283: 13009-13020.
11. Taylor RP, Geisler TS, Chambers JH, McClain DA, (2009) Up-regulation of O-GlcNAc transferase with Glucose deprivation in HepG2 cells is mediated by deceased hexamine pathway flux. J Biol Chem 284: 3428-3432.
12. Kang JG, Park SY, Ji S, Jang I, Park S, et al. (2009) O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation. J Biol Chem 284: 34777-34784.
13. Ngoh GA, Hamid T, Prabhu SD, Jones SP, (2009) O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death. Am J Physiol Heart Circ Physiol 297: H1711-H1719.
14. Cueva., Cotano C, Larriba G, (1998) N-Glycosylation by transfer of GlcNAc2 from dolichol-PP- GlcNAc2 to the protein moiety of the major yeast exoglucanase. Yeast 14: 773-781.
15. Kukuruzinska MA, Lennon K, (1994) Growth-ralated coordinate regulation of the early N-Glycosylation genes in yeast. Glycobiol 4: 437-443.
16. Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW, (2001) Characterization of a mouse monoclonal antibody specific for O-linked N-Acetylglucosamin. Anal Biochem 293: 169-177.
17. Samuelson J, Benerjee S, Magnelli P, Cui J, Kelleher DJ, et al. (2005) The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases. Proc Natl Acad Sci 102: 1548-1553.
18. Haeuptle M, Hennet T, (2009) Congenital disorder of glycosylation: An update on defects affecting the biosynthesis of dolichol-linked oligosaccharides. Human Mutation 130: 1-14.
19. Grubenmann CE, Frank CG, Hulsmeier J, Schillen E, Matthijs G, et al. (2004) Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. Human Mol Genetics 13: 535-542.
20. Menniti M, Iuliano R, Amato R, Boito R, Corea M, et al. (2004) Serum and Glucocorticoid-regulated kinase Sgk1 inhibits insulin-dependent activation of phosphomannomutase 2 in transfected COS-7 cells. Am J Physiol Cell Physiol 288: C148-C155.
21. Bubenik J, Baresiva M, Viklicky V, Jakoubkova J, Sainerova H, et al. (1973) Established cell line of urinary bldder carcinma (T24) containing tumour-specific antigen. Int J Cancer 11: 766-773.
22. Dubridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
23. Kim CJ, Isono T, Tambe Y, Chano T, Okabe H, et al. (2008) Role of alternative splicing of periostin in human bladder carcinogenesisi. Int J Oncol 32: 161-169.
24. Isono T, Tanaka T, Kageyama S, Yoshiki, (2002) Structural diversity of cancer-related and non-cancer-related prostate-specific antigen. Clin Chem 48: 2187-2194.